Targeting the KRAS, p38α, and NF-κB in lung adenocarcinoma cancer cells: The effect of combining RNA interferences with a chemical inhibitor

Potential Molecular Targets in the Treatment of Lung Cancer Using siRNA Technology

(2018) Habib Zarredar et al.   CANCER INVESTIGATION

Critical Micrornas in Lung Cancer: Recent Advances and Potential Applications

(2018) Habib Zarredar et al.   Anti-Cancer Agents in Medicinal Chemistry

Combination therapy with KRAS siRNA and EGFR inhibitor AZD8931 suppresses lung cancer cell growth in vitro

(2018) Habib Zarredar et al.   JOURNAL OF CELLULAR PHYSIOLOGY

Cancer statistics, 2016

(2016) Rebecca L. Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Targeting the KRAS Pathway in Non-Small Cell Lung Cancer

(2016) P. Tomasini et al.   ONCOLOGIST

RAS-MAPK dependence underlies a rational polytherapy strategy in EML4-ALK–positive lung cancer

(2015) Gorjan Hrustanovic et al.   NATURE MEDICINE

The effects of p38 gene silencing on breast cancer cells

(2014) Fulya Doğaner et al.   MOLECULAR BIOLOGY REPORTS

Therapeutic Silencing of KRAS Using Systemically Delivered siRNAs

(2014) C. V. Pecot et al.   MOLECULAR CANCER THERAPEUTICS

Clinicopathologic Features of Patients with Non-Small Cell Lung Cancer Harboring the EML4-ALK Fusion Gene: A Meta-Analysis

(2014) Ying Wang et al.   PLoS One

Effect of crizotinib on overall survival in patients with advanced non-small-cell lung cancer harbouring ALK gene rearrangement: a retrospective analysis

(2011) Alice T Shaw et al.   LANCET ONCOLOGY

Genetic and epigenetic changes in lung carcinoma and their clinical implications

(2011) Jing Wen et al.   MODERN PATHOLOGY

Knockdown of Oncogenic KRAS in Non-Small Cell Lung Cancers Suppresses Tumor Growth and Sensitizes Tumor Cells to Targeted Therapy

(2011) N. Sunaga et al.   MOLECULAR CANCER THERAPEUTICS

NF-kappaB in lung cancer, a carcinogenesis mediator and a prevention and therapy target

(2010) Wenshu Chen   Frontiers in Bioscience-Landmark

Inhibition of the p38 Kinase Suppresses the Proliferation of Human ER-Negative Breast Cancer Cells

(2009) L. Chen et al.   CANCER RESEARCH

The p38 MAPK inhibitors for the treatment of inflammatory diseases and cancer

(2009) Hae-Young Yong et al.   EXPERT OPINION ON INVESTIGATIONAL DRUGS

KRAS mutations and resistance to EGFR-TKIs treatment in patients with non-small cell lung cancer: A meta-analysis of 22 studies

(2009) Chen Mao et al.   LUNG CANCER

Pten Inactivation Accelerates Oncogenic K-ras-Initiated Tumorigenesis in a Mouse Model of Lung Cancer

(2008) K. Iwanaga et al.   CANCER RESEARCH

EML4-ALK Fusion Gene and Efficacy of an ALK Kinase Inhibitor in Lung Cancer

(2008) J. P. Koivunen et al.   CLINICAL CANCER RESEARCH

Phosphorylation of Fibroblast Growth Factor (FGF) Receptor 1 at Ser777 by p38 Mitogen-Activated Protein Kinase Regulates Translocation of Exogenous FGF1 to the Cytosol and Nucleus

(2008) V. Sorensen et al.   MOLECULAR AND CELLULAR BIOLOGY